MET and hepatocellular carcinoma: Rui et al. [26] found that STMN1 mediates interactions between hepatocellular carcinoma cells and hepatic stellate cells through the Hepatocyte Growth Factor/MET signaling pathway, influencing tumor behavior and prognosis.